Concepedia

Author

Bennett C. Laguzza

Eli Lilly (United States)

Also Known As

B C Laguzza, Bennett C. Laguzza

7

Publications

332

Citations

7

H-Index

23

Concepts

All Affiliations

Eli Lilly (United States)
BC

About

Bennett C. Laguzza is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

193

2

Biomolecular Engineering

2

2

219

3

Engineering

1

1

94

4

Biochemistry

1

1

23

5

Cell Biology

1

1

30

Bennett C. Laguzza

×

6

Publications

300

Citations

6

H-Index

YearCitations

New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity

Bennett C. Laguzza, Cynthia L. Nichols, George J. Cullinan,

Journal of Medicinal Chemistry

1989

125

A new protecting group for amines. Synthesis of anticapsin from L-tyrosine

Bennett C. Laguzza, Bruce Ganem

Tetrahedron Letters

1981

94

Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.

David A. Johnson, Bennett C. Laguzza

PubMed

1987

30

Total synthesis of 12-()-10-hydroxy--11,12-epoxyeicosa-5,9,14-()-trienoic acids, metabolites of arachidonic acid in mammalian blood platelets

E. J. Corey, Jahyo Kang, Bennett C. Laguzza,

Tetrahedron Letters

1983

23

Antitumor activity of L/1C2-4-desacetylvinblastine-3-carboxhydrazide immunoconjugate in xenografts.

David A. Johnson, Audrey Baker, Bennett C. Laguzza,

PubMed

1990

15

In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen

James J. Starling, Ronald S. Maciak, N. Ann Hinson,

Bioconjugate Chemistry

1992

13

Page 1